Anavex Life Sciences Corp... (AVXL)
NASDAQ: AVXL
· Real-Time Price · USD
9.71
-0.23 (-2.36%)
At close: Aug 18, 2025, 10:38 AM
-2.36% (1D)
| Bid | 9.68 |
| Market Cap | 834.33M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -47.14M |
| EPS (ttm) | -0.57 |
| PE Ratio (ttm) | -17.04 |
| Forward PE | 7.85 |
| Analyst | Buy |
| Ask | 9.75 |
| Volume | 219,647 |
| Avg. Volume (20D) | 1,055,150 |
| Open | 9.90 |
| Previous Close | 9.95 |
| Day's Range | 9.70 - 10.03 |
| 52-Week Range | 4.93 - 14.44 |
| Beta | 0.80 |
About AVXL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AVXL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AVXL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+8.21%
Anavex Life Sciences shares are trading higher aft...
Unlock content with
Pro Subscription
7 months ago
+29.55%
Anavex Life Sciences shares are trading higher after the company announced better-than-expected Q4 financial results.
5 days ago · seekingalpha.com
Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call TranscriptAnavex Life Sciences Corp. (NASDAQ:AVXL ) Q3 2025 Earnings Conference Call August 12, 2025 8:00 AM ET Company Participants Christopher U. Missling - President, CEO, Secretary & Director Clint Tomlinso...
